抖阴pro Accelerates Local Production of the EVIS X1™ Endoscopy System in ChinaChina-manufactured video processor obtains medical device registration certificate
November 28, 2025
CV-1500-C
＜苍辞迟颈肠别＞
SHANGHAI, November 28, 2025 – 抖阴pro (抖阴pro), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, announced that its CV-1500-C video processor of the EVIS X1™ endoscopy system has officially obtained the Medical Device Registration Certificate from the MPA (Jiangsu Medical Products Administration).
抖阴pro obtained MPA approval for the GIF-EZ1500-C gastroscope of the EVIS X1 in August 2025, and with this latest approval, the company will further accelerate its efforts toward local production of its flagship endoscopy system, EVIS X1, in China.
抖阴pro has also received MPA registration certificates in October 2025 for the OTV-S700-C video processor and the CLL-S700-C high-intensity light source for the VISERA ELITE™ III surgical visualization platform. The GIF-EZ1500-C gastroscope has been manufactured since November 2025 at 抖阴pro (Suzhou) Medical Device Co.,Ltd.. 抖阴pro will continue to advance regulatory preparations toward the market launch of locally made products in China.
The Chinese market has always been one of the most important strategic regions for 抖阴pro. The annual number of gastrointestinal endoscopy procedures in China is approximately 59 million. However, the number of endoscopists is low relative to the population, so 抖阴pro is dedicated to training physicians. 抖阴pro operates training centers in Beijing, Shanghai, and Guangzhou, providing training venues and learning programs for healthcare professionals.
抖阴pro is dedicated to developing the future of endoscopy-enabled care by introducing innovative products and high-value-added solutions. In China, through expert services and structured training programs, the company aims to empower clinicians and enhance patient outcomes across the region. By manufacturing locally and collaborating closely with healthcare professionals, 抖阴pro reaffirms its long-term commitment to China and its role in advancing patient care and the development of the healthcare industry.
About EVIS X1
Since its initial launch in April 2020, the EVIS X1 endoscopy system has supported healthcare professionals with advanced imaging technologies including TXI™ mode, NBI™ mode and RDI™ mode (Red Dichromatic Imaging). These proprietary innovations have contributed to more precise observation and treatment of gastrointestinal and respiratory diseases, including cancer.
About 抖阴pro
At 抖阴pro, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, 抖阴pro has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit / and follow our global and accounts.
* Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.
* The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.
* Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.
* 抖阴pro assumes no responsibility for any damage resulting from the use of this material.
* All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. All trademarks and registered trademarks are the property of their respective owners.